The use of silastic transhepatic stents in benign and malignant biliary strictures.

PubWeight™: 1.60‹?› | Rank: Top 4%

🔗 View Article (PMC 1396841)

Published in Ann Surg on October 01, 1978

Authors

J L Cameron, B W Gayler, G D Zuidema

Articles citing this

Accidental lesions of the common bile duct at cholecystectomy. Pre- and perioperative factors of importance. Ann Surg (1985) 1.94

Benign postoperative biliary strictures. Operate or dilate? Ann Surg (1989) 1.71

Accidental lesions of the common bile duct at cholecystectomy. II. Results of treatment. Ann Surg (1985) 1.67

A technique of biliary tract reconstruction with complete follow-up in 44 consecutive cases. Ann Surg (1981) 1.48

Proximal bile duct tumors: surgical management with silastic transhepatic biliary stents. Ann Surg (1982) 0.91

Low-pressure continuous suction of bile and pancreatic juice from the hepatic duct and jejunal limb after major hepatectomy with pancreatoduodenectomy. Surg Today (2008) 0.87

Percutaneous transhepatic management of complex biliary problems. Ann Surg (1983) 0.87

Management of injuries to the porta hepatis. Ann Surg (1985) 0.85

Central hepatic resection and anastomosis for stricture or carcinoma at the hepatic bifurcation. Ann Surg (1980) 0.83

External metallic circle in hepaticojejunostomy. BMC Surg (2004) 0.76

Placement of percutaneous transhepatic biliary stent using a silicone drain with channels. World J Gastroenterol (2009) 0.75

Obstructive biliary tract disease. West J Med (1982) 0.75

The current role of U tubes for benign and malignant biliary obstruction. Ann Surg (1993) 0.75

National Scientific Medical Meeting. The Royal College of Physicians of Ireland. Dublin, 8-9 April 1994. Abstracts. Ir J Med Sci (1994) 0.75

Articles by these authors

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg (1997) 8.86

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg (2001) 8.34

The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg (1995) 5.95

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg (1995) 5.66

Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg (1987) 5.58

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42

A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg (1995) 4.24

Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg (1998) 4.19

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res (2001) 4.19

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg (1997) 3.90

Clinical prediction rule for pulmonary infiltrates. Ann Intern Med (1990) 3.81

K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol (1993) 3.56

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol (2001) 3.27

Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg (1993) 3.17

Pyogenic hepatic abscess. Changing trends over 42 years. Ann Surg (1996) 3.13

Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg (1999) 3.09

The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02

Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg (2000) 2.94

Selective nonoperative management of contained intrathoracic esophageal disruptions. Ann Thorac Surg (1979) 2.90

Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg (2001) 2.80

Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg (1998) 2.60

Chronic pancreatic ascites and pancreatic pleural effusions. Gastroenterology (1978) 2.60

Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg (1997) 2.53

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res (2001) 2.50

Postoperative bile duct strictures: management and outcome in the 1990s. Ann Surg (2000) 2.50

Acute pancreatitis with hyperlipemia: the incidence of lipid abnormalities in acute pancreatitis. Ann Surg (1973) 2.47

Factors affecting mortality in biliary tract surgery. Am J Surg (1981) 2.41

Laparoscopic cholecystectomy-related bile duct injuries: a health and financial disaster. Ann Surg (1997) 2.41

Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg (1999) 2.37

Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg (1999) 2.36

Measuring the quality of medical care: second revision of tables of indexes. N Engl J Med (1980) 2.34

Choledochal cyst disease. A changing pattern of presentation. Ann Surg (1994) 2.33

Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg (1998) 2.32

Surgical management of unresectable carcinoma of the pancreas. Surgery (1982) 2.30

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg (1995) 2.28

Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg (1993) 2.26

Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg (1999) 2.23

Equivocal mammographic findings: evaluation with spot compression. Radiology (1989) 2.21

Cecal volvulus: analysis of 50 patients with long-term follow-up. Ann Surg (1979) 2.13

Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol (1988) 2.03

Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg (2000) 2.00

The clinical significance of retroperitoneal fibrosis. Surgery (1977) 1.99

Preoperative recognition of intestinal strangulation obstruction. Prospective evaluation of diagnostic capability. Am J Surg (1983) 1.99

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98

Paranasal sinuses: CT imaging requirements for endoscopic surgery. Radiology (1987) 1.96

The role of oxygen-derived free radicals in the pathogenesis of acute pancreatitis. Ann Surg (1984) 1.92

Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) (1982) 1.92

Factors influencing mortality in the treatment of pyogenic hepatic abscess. Surg Gynecol Obstet (1975) 1.91

STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (2001) 1.89

Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg (2000) 1.86

Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg (1998) 1.83

The natural history of pancreatic pseudocysts documented by computed tomography. Surg Gynecol Obstet (1990) 1.83

Internal pancreatic fistulas: pancreatic ascites and pleural effusions. Ann Surg (1976) 1.82

Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol (2000) 1.81

Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol (1994) 1.79

Acute pancreatitis with hyperlipemia. Surgery (1971) 1.79

Sclerosing cholangitis: biliary reconstruction with Silastic transhepatic stents. Surgery (1983) 1.77

Surgical management of Crohn's disease. Influence of disease at margin of resection. Ann Surg (1980) 1.75

Acute pancreatitis with hyperlipemia: studies with an isolated perfused canine pancreas. Surgery (1977) 1.73

Reoperative surgery for periampullary adenocarcinoma. Arch Surg (1991) 1.73

Major bile duct injuries during laparoscopic cholecystectomy. Follow-up after combined surgical and radiologic management. Ann Surg (1997) 1.72

Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg (2002) 1.72

Benign postoperative biliary strictures. Operate or dilate? Ann Surg (1989) 1.71

DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol (1998) 1.71

Current management of the Budd-Chiari syndrome. Ann Surg (1990) 1.68

Solid and papillary epithelial neoplasms of the pancreas. Surgery (1990) 1.68

Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg (1996) 1.67

Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg (1999) 1.65

Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes. J Am Coll Surg (1999) 1.64

Image quality and radiation levels in videofluoroscopy for swallowing studies: a review. Dysphagia (1990) 1.64

Clinical management of acute cholangitis. Surg Gynecol Obstet (1976) 1.62

Current status of surgical palliation of periampullary carcinoma. Surg Gynecol Obstet (1993) 1.61

Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol (1999) 1.59

Choledochal cysts: classification and cholangiographic appearance. AJR Am J Roentgenol (1991) 1.59

Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol (1994) 1.59

Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg (1980) 1.58

Diagnosis and management of the Budd-Chiari syndrome. Am J Surg (1990) 1.58

Laparoscopic cholecystectomy. Ann Surg (1991) 1.58

Cystadenomas of the pancreas: is enucleation an adequate operation? Ann Surg (1998) 1.58

Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy. Ann Surg (1991) 1.55

Acute pancreatitis with hyperlipemia. Evidence for a persistent defect in lipid metabolism. Am J Med (1974) 1.55

Management of patients with carcinoma of the pancreas. J Am Coll Surg (1995) 1.53

Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg (1985) 1.53

Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg (1999) 1.53

The treatment of pancreatic ascites. Ann Surg (1969) 1.50

Short-term neuroendocrine effects of a large oral dose of monosodium glutamate in fasting male subjects. J Clin Endocrinol Metab (1996) 1.49

The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg (1990) 1.48

Carcinoma of the body and tail of the pancreas. Am J Surg (1992) 1.48

Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol (2001) 1.46

Prognostic factors in ductal pancreatic cancer. Langenbecks Arch Surg (1998) 1.45

Spectrum of cystic tumors of the pancreas. Am J Surg (1992) 1.45